Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies.

MLA

Kummar, Shivaani, et al. “Phase 0 Clinical Trials: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies.” European Journal of Cancer (Oxford, England : 1990), vol. 45, no. 5, Mar. 2009, pp. 741–46. EBSCOhost, https://doi.org/10.1016/j.ejca.2008.10.024.

APA

Kummar, S., Doroshow, J. H., Tomaszewski, J. E., Calvert, A. H., Lobbezoo, M., & Giaccone, G. (2009). Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies. European Journal of Cancer (Oxford, England : 1990), 45(5), 741–746. https://doi.org/10.1016/j.ejca.2008.10.024

Chicago

Kummar, Shivaani, James H Doroshow, Joseph E Tomaszewski, A Hilary Calvert, Marinus Lobbezoo, and Giuseppe Giaccone. 2009. “Phase 0 Clinical Trials: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies.” European Journal of Cancer (Oxford, England : 1990) 45 (5): 741–46. doi:10.1016/j.ejca.2008.10.024.